The largest database of trusted experimental protocols

Zli 811

Manufactured by Merck Group

ZLI-811 is a laboratory equipment product manufactured by Merck Group. It is a precision instrument designed for specialized laboratory applications. The core function of ZLI-811 is to perform accurate measurements and analyses in a controlled environment.

Automatically generated - may contain errors

2 protocols using zli 811

1

Synthesis of Left-Handed Chiral Microparticles

Check if the same lab product or an alternative is used in the 5 most similar protocols
The left-handed chiral microparticles are prepared through the following steps. First, a pure reactive mesogen contained in RMS03-001C blend (Merck, Germany) is obtained extracting its solvent PGMEA (propylene glycol monomethyl ether acetate) by vacuum evaporation at 90 °C. Thus, this is mixed with a left-chiral dopant (ZLI-811, Merck) at concentration of 23% wt. yielding a CLC phase. Then, a CLC droplet emulsion is prepared with type I ultrapure water (18.2 MΩ cm resistivity at 25 °C, < 5 ppb total organic carbon). The values of the extraordinary and ordinary refractive indices of the reactive mesogen at 500 nm are respectively n// = 1.68 and n = 1.53. The emulsion is polymerized in nitrogen environment for at least 4 hours under a 2 mW cm−2 intensity UV lamp (Mega Electronics lamp mod. LV202-E) having emission wavelength centred at 350 nm. The size of the solid chiral particles produced by this method ranges from hundreds of nanometres up to tens of microns. The resulting helicoidal pitch p, is approximately 0.3 μm. Finally, a few tens of microliters of the chiral particles suspension are loaded in a small glass chamber for OT experiments.
+ Open protocol
+ Expand
2

Photocurable Liquid Crystal Coatings

Check if the same lab product or an alternative is used in the 5 most similar protocols
LC monomers 4-[[[4-[(1-Oxo-2-propenyl)oxy]butoxy]carbonyl]oxy]benzoic
acid 2-methyl-1,4-phenylene ester (LC242) and 4-Methoxybenzoic acid
4-(6-acryloyloxy-hexyloxy)phenyl ester (C6BP) were acquired from BASF
and Synthon, respectively. Photoinitiator camphorquinone (CQ) was
purchased from ABCR. Co-initiator ethyl 4-(Dimethylamino)benzoate
(EDAB) and photoinhibitor 2,2′-Bis(2-chlorophenyl)-4,4′,5,5′-tetraphenyl-1,2′-biimidazole
(o-Cl-HABI) were obtained from TCI. Chiral dopant
benzoic acid, 4-hexyl-,4-[[(1-methylheptyl)oxy]carbonyl]phenyl ester
(ZLI-811), was acquired from Merck.
Coatings used for cell preparation
included OPTMER AL 1254 from JSR (planar alignment), Sunever 5661
from Nissan Chemical (homeotropic alignment), 3-(trimethoxysilyl)propyl
methacrylate (adhesive coating), and trimethoxy(octadecyl)silane (antiadhesive
coating) from Sigma-Aldrich.
The developer solution comprised
isopropyl alcohol (IPA) from Biosolve,
propylene glycol monomethyl ether acetate (PGMEA) from Aldrich, and
methyl isobutyl ketone (MIBK) from Acros Organics. Dichloromethane
(DCM) and tetrahydrofuran (THF) were purchased from Biosolve.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!